Lyme disease vaccine: Valneva reports positive second Phase 2 data
by Press Release from Outbreak News Today on (#59BWE)
By NewsDesk @bactiman63 Specialty vaccine company, Valneva, today announced positive initial results for its second Phase 2 study (VLA15-202) of Lyme disease vaccine candidate VLA15. Compared to study VLA15-201, study VLA15-202 investigated a vaccination schedule of Month 0-2-6 based on matching doses. VLA15 was generally safe across all doses and age groups tested. The tolerability profile [...]
The post Lyme disease vaccine: Valneva reports positive second Phase 2 data appeared first on Outbreak News Today.